Diverse patient base Leverage IMD’s access to a highly diverse patient population to propose targeted healthcare services, inclusive clinical trial recruitment, and payer strategies that address broad socioeconomic needs.

Research funding leverage With over $220 million in research funding and more than 500 principal investigators, present opportunities for sponsor collaborations, translational research programs, and technology commercialization partnerships.

Clinical trial ecosystem Capitalize on IMD’s network of 700+ clinical trials by offering patient recruitment tech, trial management software, data analytics, and site optimization services to accelerate study timelines.

Development potential 28 acres of development-ready land create a venue for partnerships in real estate, healthcare facilities, biotech incubators, or academic–industry campuses to expand capacity and services.

Community and scale Position value propositions around scalable solutions for large-scale health systems and academic partners, aligning with IMD’s ecosystem of hospitals, researchers, and private industry to drive joint ventures and revenue sharing models.